|
1
|
Damsky WE and Bosenberg M: Melanocytic
nevi and melanoma: Unraveling a complex relationship. Oncogene.
36:5771–5792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tripp MK, Watson M, Balk SJ, Swetter SM
and Gershenwald JE: State of the science on prevention and
screening to reduce melanoma incidence and mortality: The time is
now. CA Cancer J Clin. 66:460–480. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiarion-Sileni V, Guida M, Ridolfi L,
Romanini A, Del Bianco P, Pigozzo J, Brugnara S, Colucci G, Ridolfi
R and De Salvo GL; Italian Melanoma Intergroup (IMI), : Central
nervous system failure in melanoma patients: Results of a
randomised, multicentre phase 3 study of temozolomide- and
dacarbazine-based regimens. Br J Cancer. 104:1816–1821. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim C, Lee CW, Kovacic L, Shah A, Klasa R
and Savage KJ: Long-term survival in patients with metastatic
melanoma treated with DTIC or temozolomide. Oncologist. 15:765–771.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jahangirian H, Kalantari K, Izadiyan Z,
Rafiee-Moghaddam R, Shameli K and Webster TJ: A review of small
molecules and drug delivery applications using gold and iron
nanoparticles. Int J Nanomedicine. 14:1633–1657. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jindal AB: The effect of particle shape on
cellular interaction and drug delivery applications of micro- and
nanoparticles. Int J Pharm. 532:450–465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoshyar N, Gray S, Han H and Bao G: The
effect of nanoparticle size on in vivo pharmacokinetics and
cellular interaction. Nanomedicine (Lond). 11:673–692. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Samanta D, Meiser JL and Zare RN:
Polypyrrole nanoparticles for tunable, pH-sensitive and sustained
drug release. Nanoscale. 7:9497–9504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sheng W, He S, Seare WJ and Almutairi A:
Review of the progress toward achieving heat confinement-the holy
grail of photothermal therapy. J Biom Opt. 22:809012017. View Article : Google Scholar
|
|
10
|
Zhang X, Du J, Guo Z, Yu J, Gao Q, Yin W,
Zhu S, Gu Z and Zhao Y: Efficient near infrared light triggered
nitric oxide release nanocomposites for sensitizing mild
photothermal therapy. Adv Sci (Weinh). 6:18011222018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
D'Acunto M: Detection of intracellular
gold nanoparticles: An overview. Materials (Basel). 11:E8822018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doughty ACV, Hoover AR, Layton E, Murray
CK, Howard EW and Chen WR: Nanomaterial applications in
photothermal therapy for cancer. Materials (Basel). 12:E7792019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim H, Chung K, Lee S, Kim DH and Lee H:
Near-infrared light-responsive nanomaterials for cancer
theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol.
8:23–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou B, Li Y, Niu G, Lan M, Jia Q and
Liang Q: Near-infrared organic dye-based nanoagent for the
photothermal therapy of cancer. ACS Appl Mater Interfaces.
8:29899–29905. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Y, Chen Q, Zhu Q, Liu J, Li Y, Gao X,
Chen D and Zhu X: Small-molecular theranostic assemblies
functionalized by doxorubicin-hyaluronic acid-methotrexate prodrug
for multiple tumor targeting and imaging-guided combined
chemo-photothermal therapy. Mol Pharm. 16:2470–2480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu B, Wan B, Lu ST, Deng K, Li XQ, Wu BL,
Li YS, Liao RF, Huang SW and Xu HB: Near-infrared light-triggered
theranostics for tumor-specific enhanced multimodal imaging and
photothermal therapy. Int J Nanomed. 12:4467–4478. 2017. View Article : Google Scholar
|
|
17
|
Hu X, Tian H, Jiang W, Song A, Li Z and
Luan Y: Rational design of IR820- and ce6-based versatile micelle
for single NIR laser-induced imaging and dual-modal Phototherapy.
Small. 14:e18029942018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hildebrandt B, Wust P, Ahlers O, Dieing A,
Sreenivasa G, Kerner T, Felix R and Riess H: The cellular and
molecular basis of hyperthermia. Crit Rev Oncol Hematol. 43:33–56.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Peng J, Tan L, Wu J, Shi K, Qu Y,
Wei X and Qian Z: Mild photothermal therapy/photodynamic
therapy/chemotherapy of breast cancer by Lyp-1 modified
Docetaxel/IR820 Co-loaded micelles. Biomaterials. 106:119–133.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mukherjee A, Waters AK, Kalyan P, Achrol
AS, Kesari S and Yenugonda VM: Lipid-polymer hybrid nanoparticles
as a next-generation drug delivery platform: State of the art,
emerging technologies, and perspectives. Int J Nanomedicine.
14:1937–1952. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mandal B, Bhattacharjee H, Mittal N, Sah
H, Balabathula P, Thoma LA and Wood GC: Core-shell-type
lipid-polymer hybrid nanoparticles as a drug delivery platform.
Nanomedicine. 9:474–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Matos MBC, Beztsinna N, Heyder C, Fens
MHAM, Mastrobattista E, Schiffelers RM, Leneweit G and Kok RJ:
Thermosensitive liposomes for triggered release of cytotoxic
proteins. Eur J Pharm Biopharm. 132:211–221. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Turner DC, Moshkelani D, Shemesh CS, Luc D
and Zhang H: Near-infrared image-guided delivery and controlled
release using optimized thermosensitive liposomes. Pharm Res.
29:2092–2103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tong L, Liao Q, Zhao Y, Huang H, Gao A,
Zhang W, Gao X, Wei W, Guan M, Chu PK and Wang H: Near-infrared
light control of bone regeneration with biodegradable photothermal
osteoimplant. Biomaterials. 193:1–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Albert C, Huang N, Tsapis N, Geiger S,
Rosilio V, Mekhloufi G, Chapron D, Robin B, Beladjine M, Nicolas V,
et al: Bare and sterically stabilized PLGA nanoparticles for the
stabilization of pickering emulsions. Langmuir. 34:13935–13945.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li B, Xu H, Li Z, Yao M, Xie M, Shen H,
Shen S, Wang X and Jin Y: Bypassing multidrug resistance in human
breast cancer cells with lipid/polymer particle assemblies. Int J
Nanomedicine. 7:187–197. 2012.PubMed/NCBI
|
|
27
|
Chen J, Shao R, Zhang XD and Chen C:
Applications of nanotechnology for melanoma treatment, diagnosis,
and theranostics. Int J Nanomedicine. 8:2677–2688. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Silva IP and Long GV: Systemic therapy in
advanced melanoma: Integrating targeted therapy and immunotherapy
into clinical practice. Curr Opin Oncol. 29:484–492. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yingchoncharoen P, Kalinowski DS and
Richardson DR: Lipid-Based drug delivery systems in cancer therapy:
What is available and what is yet to come. Pharmacol Rev.
68:701–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sah H, Thoma LA, Desu HR, Sah E and Wood
GC: Concepts and practices used to develop functional PLGA-based
nanoparticulate systems. Int J Nanomedicine. 8:747–765. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ananta JS, Paulmurugan R and Massoud TF:
Temozolomide- loaded PLGA nanoparticles to treat glioblastoma
cells: A biophysical and cell culture evaluation. Neurol Res.
38:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheow WS and Hadinoto K: Factors affecting
drug encapsulation and stability of lipid-polymer hybrid
nanoparticles. Colloids Surf B Biointerfaces. 85:214–220. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen WR, Singhal AK, Liu H and Nordquist
RE: Antitumor immunity induced by laser immunotherapy and its
adoptive transfer. Cancer Res. 61:459–461. 2001.PubMed/NCBI
|
|
34
|
Hu Y, Chi C, Wang S, Wang L, Liang P, Liu
F, Shang W, Wang W, Zhang F, Li S, et al: A comparative study of
clinical intervention and interventional photothermal therapy for
pancreatic cancer. Adv Mater. 29:2017. View Article : Google Scholar
|
|
35
|
Hunyadi A, Csabi J, Martins A, Molnar J,
Balazs A and Toth G: Backstabbing P-gp: Side-chain cleaved
ecdysteroid 2,3-dioxolanes hyper-sensitize MDR cancer cells to
doxorubicin without efflux inhibition. 22:E1992017.PubMed/NCBI
|
|
36
|
Chen HH, Lu IL, Liu TI, Tsai YC, Chiang
WH, Lin SC and Chiu HC: Indocyanine green/doxorubicin-encapsulated
functionalized nanoparticles for effective combination therapy
against human MDR breast cancer. Colloids Surf B Biointerfaces.
177:294–305. 2019. View Article : Google Scholar : PubMed/NCBI
|
